Skip to main content

Stem Cell Transplant

Researchers working with stem cells

Stem cell transplants, also called bone marrow transplants, treat high-risk and life-threatening blood diseases. If you have leukemia, lymphoma, or other blood cancer, a stem cell transplant could be the right option for you. 

A stem cell transplant still requires chemotherapy and sometimes, radiation. However, if successful, a stem cell transplant can offer a lot of hope. 

Find out what to expect from the bone marrow transplant procedure and recovery. More questions? Read our FAQs.

Curing Blood Disease

The stem cell transplant team at UVA Health guides us through the transplant process.

Stem Cell Transplant at UVA Health

At UVA Health, you can trust in our excellent outcomes and deep experience in providing bone marrow transplants. The honors we've earned show the high quality of our care. We've been recognized:

  • With the Federation for Accreditation of Cell Therapy (FACT), the highest level of accreditation possible
  • With National Marrow Donor Program (NMDP) Be The Match registry approval 
  • As a Center of Excellence, by many insurance companies

Stem Cell Research & Clinical Trials

We're at the cutting edge of stem cell transplant research. When you come to UVA Health, you'll have access to: 

  • Teams of doctors, nurses, and support staff specifically trained in bone marrow, stem cell, and umbilical cord transplants
  • A team accessible to you 24/7
  • The most modern and effective treatments
  • Treatment options not available anywhere else, through clinical trials

Taking part in a clinical trial means you get the very latest medicine. Talk to our team about how you can join an open clinical trial.

Is Blood Cancer Curable?

Stem Cell Transplant Clinical Trials
Protocol for a Research Database for Hematopoietic Cell Transplantation, Other Cellular Therapies, and Marrow Toxic Injuries

The University of Virginia Cancer Center seeks participants for a Research Database that collects data on the outcomes of stem cell transplants and other cellular treatments. The Research Database is a comprehensive source of data that can be used to study hematopoietic cell transplantation (HCT) and cellular therapy (CT). The sponsor of this study, the Center for International Blood and Marrow Transplant Research (CIBMTR) uses the data in order to find ways to make bone marrow and stem cell transplants work better for both recipients and donors. Medical data about your disease and your treatment will be reported to the CIBMTR. Participating in this Research Database will not cost you any money. Your insurance company will also not be billed. Additional information can be found here: https://clinicaltrials.gov/study/NCT04920474 [email protected] The (department, division name) seeks (insert as applies: adults/men/women/adolescents/children) ages (insert) with (insert condition) for a research study. The purpose of the study is (insert purpose of study - eg.to test the effectiveness of an investigational medicine; or to find out how stress effects blood pressure.) (Optional)You may be eligible for this study if: (insert brief eligibility criteria 3 or 4 top criteria and in lay language. Do not copy eligibility criteria from the protocol) Study involves (insert procedures-examples: taking an experimental medicine/placebo, blood draws, x rays, overnight stays,) (Insert x number of visits every x (weeks, months,) each visit lasting x amount of time or give range). Insert one of the following: Study-related (insert exams, tests and experimental medication) provided at no cost. or Participant’s insurance company will be billed for medication, tests and procedures

Blood Sample Banking For Future Research

The UVA Cancer Center seeks adults over the age of 18 to participate in a research study to store blood samples in a repository for future research. A repository is like a bank, where blood samples are frozen and stored. The exact research that will be done on the stored samples is not known at this time; however, researchers may use these samples to learn more about: • What affects transplant and cellular therapy results • The distribution of tissue type in populations • How to match donors and patients for bone marrow transplants If you agree to participate, you will be asked to provide about 2 tablespoons of blood before your transplant or cellular therapies. If you agree to participate and you are a donor, 2 tablespoons of blood will be collected before or shortly after your donation. In the future, we may ask you for another blood sample and at that time, you can choose to give another sample if you want to. Study-related (insert exams, tests and experimental medication) provided free of charge.

A phase 2, open-label, single-arm, multicohort, multicenter trial to evaluate the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory indolent B-cell non-hodgkin lymphoma (NHL)

The University of Virginia Cancer Center seeks participants 18 years old or above to participate in a study that looks at a new treatment for follicular or marginal zone lymphoma that has not responded to or returned after previous treatments. The JCAR-017 treatment works on the T-cells in the body (part of the immune system). Participation on this study involves up to 26 weeks. Participants are also required to take part in a 15-year long-term follow up study. Study-related tests and procedures and study drug will be covered by the study sponsor. Additional information can be found here: https://clinicaltrials.gov/ct2/show/NCT04245839

View All Clinical Trials
Help Us Care for You and Your Loved Ones

Help Us Care for You and Your Loved Ones

UVA Health's Stem Cell Transplant Program doesn't just care for patients using advanced treatments, but we’re always looking for better and more effective ways of detecting, preventing and treating disease. You can help us pioneer the treatments of tomorrow.

Give

Find a Related Provider